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The present study compares rat Ih'er presen'ation 
for 9, 12, and 24 h in the standard Eurocollins 
solution with preservation for the same time peri-
ods in the new UW-Iactobionate solution. Pharma-
cologic manipulation with a potent platelet-
activating factor antagonist. SRI 63-·141. was also 
enluated. After cold storage in each of the test 
solutions. the livers underwent 90 min of warm. 
oxygenated, sanguinous perfusion. A significant in-
crease in liver weight was noted in Eurocollins-
stored \'ersus UW -Iactobionate-stored livers. After 
90 min of perfusion, livers preserved in UW-
lactobionate produced significantly more bile and 
liberated significantly less glucose and transami-
nases when compared with Eurocollins-stored liv-
ers. Significant augmentation of bile production was 
observed when donor animals were pretreated with 
SRI 63-441 and the livers were then stored in 
UW-Iactobionate for 24 h. Eurocollins-stored lh'ers 
demonstrated increased hepatocyte vacuolization 
and endothelial disruption when compared with 
UW-Iactobionate-stored lh'ers after 12 and 24 h of 
preservation. This stud}' demonstrates the superior-
ity of U\\'-lactobionate solution in liver preserva-
tion and suggests that SRI 63-441 may be beneficial 
in the further reduction of cold ischemic injury. 
T he development of a technique with the capabil-ity of preserving li\'ers for at least 24-36 h. with 
consistent and good post implantation function. 
would maximize donor use and ensure better organ 
recipient matching and sharing. Recently. Jamieson 
et al. reported successful transplantat ion of canine 
livers preserved for >20 h using simple, static 
hypothermic storage in a novel solution. known as 
the UW-Iactobionate (UW) solution (1-3). 
In the present study we have further evaluatcd the 
efficacy of static hypothermic liver preser\'ation in 
U\\' solution, by comparing it with preservation in 
standard Eurocollins [Ee) solution after 9.12. and 24 
h of cold storage. Liver function was assessed on an 
isolated perfused rat liver apparatus. modified from 
!-.filler et a!. (4), The results of these studies re\'ealed 
evidence of improved hepatic status in those livers 
presen'ed in l:\\' solution. with the greatest differ-
ence in treatment groups being exhibited after 24 h 
of preser\'ation. 
Platelet·acth·ating factor [P.\F] is a key inflamma-
tory mediator (5-i] implicated in the microcircula-
tory failure that ensues after ischemic organ injury. 
Pre\'iously we reported the protective effect of a 
platelet-actl\'atlng factor antagonist. SRI 63-441 
(Sandoz Pharmaceuticals. :-":orth Hano\'er. ~lKFK on 
post ischemic hepatic function after warm ischemic 
injury (81. 
In the present study we ha\'e irn'cstigated the rolf' 
of P:\F antagonism on hepatic function after a cold 
ischemic Insult. The results of this study suggest that 
protection of the micrO\'asculature by a combined 
approach utilizing UW solution and SRI 63·H1 can 
significanth' reduce cold ischemic injury to the !i\'er 
and result in reliable and prolonged extension of the 
preservation period. 
~faterials and ~fethods 
:\nimals 
~fale LeWIS rats ICharles River Breeding Lclborato-
ries. \\'ilmington. ~lclppK1 weighing 225-300 g were used as 
Il\er donors. and male LeWIS rat retired breeders were 
used as blood donors. Animals were acclimatized for 1 wk 
Abbr~K·iolions us~d in this mnm~r: [C. [urCKollins; PAF. plille. 
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Table 1 E.xpc.'flmrnlol Croups 
Stordgl' lime SRI 63·Hl 
Group n Ihl Solution 120 109 kgl 
1° 7 :-':0 storage 
2 5 9 EC 
J 6 9 L'W 
-I 5 12 EC 
5 6 12 L'W 
6 6 24 EC 
7 5 H L'W 
8b 6 24 L'W 
EC. Eurocollins: L'\\'. L·W-Iactobionate. 0 Livers were flushed 
with lactdted Ringer"s solution and immediately placed on the 
perfusion apparatus. b :'.nimals were Inlra\·enously pretreated 
with 20 mgkg of SRl 63·H1 5 min before harvesting the liver. 
before experimentation. housed in a standard animal fa-
cility at the l!nhersitr of Pittsburgh, and fed standard 
laboratory diet for rats and water ad libitum. 
Operath'e Procedure 
Inhalational anesthesia was induced and main-
tained with methoxyflurane. :\11 animals received 300 U of 
heparin intravenousl~D via the penile vein 5 min before 
cannulation of the bile duct and portal vein. The bile duct 
and portal vein were cannulated and, after the vena cava 
was vented. the liver was nushed \'ia the portal vein with 
20 ml of cooled (0I'e) presen ation solution from a height of 
20 cm. The Ih'er was excised during the flushing period, 
weighed. immersed in preservation solution. and stored at 
4'C. Before placement on the perfUSIon apparatus. livers 
were nushed with 8 ml of lactated Ringer's solution to 
remove the presen'ation solution. 
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Iso/l1led Pl'rfusion 
The perfuston apparatus was a reurculating system 
14.9.10) maintained at Ji'C by a circulating water bath and 
oxygenated with a 95°0 O2-5% CO2 mixture. The liver was 
perfused \'ia the portal vein from a height of 18 cm (11). 
The perfusate consisted of a dilute sanguinous solution 
prepared from 2 parts by volume of heparinized fresh 
whole rat blood and 1 part Krebs' bicarbonate buffer (12) at 
a hematocrit of 25 (13) and pH = 7.4. 
Experimental Protocol 
Experimental groups are described in Table 1. After 
storage at oI'C. all livers were nushed with Ringer's lactate 
and placed on the perfusion apparatus for 90 min. 
PJatelel-.-\cli\'ating Foetor Anlagonisl 
SRI 63-401 1. a P.\F receptor antagonist. was sup-
plied by Sandoz Pharmaceuticals. It was supplied in a 
powdered form and a 15-mg'ml sol ulion was prepared 
daily in 0.9°0 sodium chloride. The solution was warmed 
to 37°C to ensure that the SRI 63-H1 was completely 
solubilized before injection. 
.-\ssessment of Li\'er Status 
Livers were weighed immediately after han'esting 
and after the preservation period. Baseline perfusate levels 
of serum glutamiC oxaloacetic transaminase (SCOT). se-
rum glutamic pyruvic transaminase (SCPT). lactic dehy· 
drogenase (LDH). and glucose were measured before plac-
ing the liver on the perfusion apparatus. Liver function 
during perfusion was determined by measuring bile pro-
duction and SCOT. SCPT. LDH. and glucose levels in the 
perfusatE' e\ery 30 min during perfusion. Serum glutamiC 
oxaloacetic transaminase. SCPT, LDH. and glucose 1E'\eJs 
r- 12 -1 r- 24 --I 
~ Eurocolllnl ~ UW-L.clo"on.tl ea rt-iaeto~loaKtl • SRI 63-441 
Figure 1. Percentage change in liver weight during the preservation period, Liven presel"'ed in EC solution gained significantly more 
weigh I than those preserved in UW solution. The addition of SRI 63--141 did not significantly alter weight change during the 
storage period. 
"l're dl'tl'rmint'd lIsing the Technicon R.\ 500 (Techllicon 
11f~trumtDl1ts Corp .. Tarf\town. :-':.Y.). 
.\[ter 90 Intn of warm sanguinolls perfusion. the li"ers 
were perfuse.fixed via the portal vein with 2.00 0 gllltaral-
dt'hvde in 0.125 ~t cacodylate buffer. minced to 1 x 1 x 
l.mm cubes. and placed in 20°'<J glutaraldehyde for 2 h 
1141. The livers were post-fixed in buffered 2.00.0 osmium 
tetroxide. dehvdrated in ethanol. and embedded in Epon 
812. Blocks were cut using a Reichert microtome. Semi..; 
thin sections were stained with toluidine blue [or light 
microscOpy. L'ltrathin sections were collected on grids. 
stained with uran~D1 acetate and lead citrate. and observed 
with a Phillips 300 electron microscope (Phillips Elec-
tronic Instruments. ~fahwahK N.J.) (15). 
Statistics 
All \'alues were corrected to baseline by subtracting 
the \'alues obtained before placing the liver on the perfu-
sion apparatus from subsequent measurements after 30. 
60. and 90 min of perfusion. Statistical e\'aluation was 
made using analysis of variance and Student's '-test (16). 
All values are expressed as mean ::: SEM. Probability 
values of <0.05 were considered statistically significant. 
Results 
Li\'er Weight 
There was a significant increase in liver 
weight for those organs stored in EC solution when 
compared with UW-stored livers (p < 0.05). There 
were no significant differences in the weights of 
livers stored in L'W solution for H h regardless of 
pretreatment with SRI 63-44 1 (Figure 1). 
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Transaminase Release 
Serum glutamic oxaloacetic transaminase val-
ues are presented in Figure 2. Serum glutamic 
oxaloacetic transaminase and SCPT liberation into 
the perfusate was significantly higher (p < 0.01) in 
li\'ers preserved in EC solution when compared with 
controls that did not undergo preservation. The 
livers stored in UW solution did not release signifi-
cantly more SCOT into the perfusate than controls 
until after 60 min of perfusion (p < 0.05)_ Similarly. 
livers preserved in UW solution did not liberate 
significantly more SGPT into the perfusate than 
controls, except after 24 h of storage and 90 min of 
perfusion (p < 0.05). The 24-h. UW-stored. SRJ 
63-441-pretreated livers did not release significantly 
more SCOT than controls until after 90 min of 
perfusion (p < 0.05). and did not release signifi-
cantly more SCPT than controls. 
After 30 min of perfusion. there was no significant 
difference in SGOT release between UW-stored and 
EC-stored livers until after 24 h of preservation (p < 
0.05). Perfusate SCOT levels became significantly 
different between UW-stored and EC-stored Ii\'ers 
after 60 min of perfusion for those livers preserved 
for 12 and 24 h (p < 0.01). After 90 min of perfusion, 
perfusate SCOT levels were significantly lower for 
UW-stored livers when compared with EC-stored 
livers (p < 0.01). Serum glutamic pyruvic transami-
nase liberation by li\'ers stored in UW solution was 
significantly decreased when compared with livers 
stored in EC solution (p < 0.01). 
Although there was a trend of decreased transam-
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Figure 2. Perfusate SCOT levels. Differences in SCOT liberation into the perfusate are most dramaticall)' demonstrated after 24 h of 
preservation. Serum glutamic onlOlcetic transaminase release from Ih'ers stored for 24 h in UW solution is compafable to the 
\'alues at 9 and 12 h for livers stored in EC solution. Perfusate le\'els of SGPT, LDH. and glucose, and bile production followed 
a simil" pallern. 
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inase release inlhe SRI 63-441-prctrcalcd. 24-h U\\'-
slored li\'ers when compared \\'ilh 24-h U\\'-stored 
livers alone. these differrnccs were not statistically 
significant. 
laCtIC Dehydrogenase Release 
There was a significant increase in LOH liber-
ation by both lJW-stored and EC-stored Ii\'ers when 
compared with nonpreser\'ed controls (p < 0.01). 
Livers from animals pretreated with SRI 63-441. 
stored in U\V solution for 24 h. similarly released 
significantly more LOH than controls (p < 0.01). 
:\0 significant difference was found in perfusate 
LOH le\'els between livers stored in UW and livers 
stored in EC solution after 9 and 12 h: howe\·er. after 
24 h of presen·ation. there was a significant increase 
in LOH release by li\'ers preser\'ed in EC solution 
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\'erslls Ihose preserved in U\\' solution (p < 0.01) 
The addition of SRI 63-441 to the protocol did not 
further significantly reduce LOB release in livers 
stored for 24 h in lW solution. 
Perfusate Glucose Le\'els 
There was a significant increase in perfusate 
glucose levels for those livers stored in EC solution 
when compared with controls (p < 0.01). There was 
no significant increase in perfusate glucose levels for 
li\'ers preser\'ed in UW solution when compared 
with controls until after 24 h of storage (p < 0.01) 
and only after 30 and 60 min of perfusion. There was 
no significant difference in perfusate glucose levels 
between U\\'·stored Ih'ers and controls after 90 min 
of perfusion for all periods of preservation. Although 
there was a significant increase in perfusate glucose 
J 
'/ 
J 
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le\'(,ls for the H\'ers from animals pretreated with SRI 
63·44 1 a nd stored in L'\\' sol ut ion for 2-t h after 30 
min of reperfusion when compared with controls (p 
< O.OII, this difference was no longer statistically 
significant after 60 dnd 90 min of perfusion. 
There was a significant decrease in perfusate glu· 
case levels for livers stored in L!\\, solution when 
compared with EC'stored lh'ers (p < 0.051, except 
for those livers stored in L'\\' solution for 24 hand 
only after the 30- and 50·min perfusion periods. SRI 
63-Hl pretreatment resulted in no further signifi· 
cant reduction in perfusate glucose levels over livers 
stored in UW solution alone. 
Bile Production 
Bile production results followed a pattern 
similar to that seen for transaminase release. Livers 
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pfl'sened In EC solution produced significcllltly less 
bile than i III mrd late I y perfused non preseryDE~d can· 
trois Ip < 001) Bile production by L'\\'·stored li\crs 
WdS not Significantly reduced from nonprcserwd 
controls until the 24-h preservation period Ip < 
0.011. There was a Significant increase in bile pro· 
ducllon b\' the livers preserved in L'\\' solution when 
compared with EC·preserved livers Ip < 0.01). Li\" 
ers har\'ested from rats pretreated with 20 mg kg of 
SRI 63-441 intra\enously and stored in UW solution 
for 24 h produced significantly more bile than li\'ers 
presen'ed in the L'\\' solution alone Ip < 0.05) 
~forphologic holue/ion 
Light and low.magnification electron micros· 
copy reHaled extensi\'e vacuolization of hepato· 
cvles 111 the 24,h EC-preserved li\'Cfs (figure 30\ 
e' t; 
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c;gur~ -4. Eleclron micrographs ah~r 24·h pr~senDltion ()( 9700) o. Liver presened in EC solution for 24 h. :'I;ote ~woll~n mitochondria 
(M). \'acuoles (V), and endolh~lial disruption (orro,' 5). b. Liver pr~senD~d in L'\\' solution for 24 h. ~ole areas of inlact 
~ndolhelium lEI. Ar~as of ~ndoDhelial inlury were also pr~senl (nol shownl. 
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when compared with conlrols and wilh livers pre-
served in UW for 24 h (Figure 3b) regardless of 
pretreatment with SRI 63-44 1. Vacuolization was 
present to a minor extent in the 9- and 12-h EC-
preserved livers and rarely present in the g- and 12-h 
U\V-preserved livers (not shown). 
Electron microscopy revealed extensive sinusoi-
dal endothelial disruption in livers stored in EC for 
24 h (Figure 40). Livers preserved in UW solution for 
24 h also exhibited some endothelial damage in the 
sinusoids. but to a lesser extent than EC-stored lh'ers 
(Figure 4b). The sinusoidal endothelium of livers 
preserved in UW for 9 h could not be distinguished 
from the sinusoidal endothelium of non preserved 
control livers: ho\\'ever. g-h EC-preserved livers 
manifested a minor degree of endothelial damage 
(not shown) .• -\fter 12 h of preservation. both EC- and 
UW-stored livers exhibited areas of sinusoidal endo-
thelial damage interspersed with areas containing 
intact sinusoidal endothelium when compared with 
controls; however. the endothelium appeared to be 
better preserved in the livers stored in UW solution 
(not shown). Livers that were pretreated with SRl 
63-Hl and stored in L'\\' solution for 24 h did not 
demonstrate any discernable histologic improve-
ment over the livers stored in UW alone for 24 h (not 
shown). 
Discussion 
Before the den'lopment of L'\\' solution. there 
had been a resurgence of interest and enthusiasm in 
hypothermic perfusion as the method best suited for 
prolonged hepatic preservation (17-191. Simple 
hypothermic presen'ation of the rat li\'er uSing iso-
tonic citrate was much less successful than that 
obtained by continuous hypothermic perfusion 
(20.21). The consistently successful transplantation 
of canine livers after 24-30 h of cold storage in UW 
solution reported by Jamieson et al. (1) is a landmark 
event in liver presen·ation. In the present study we 
have evaluated hepatic function after 9.12. and 24 h 
of preservation with V\\' solution using the isolated 
perfused rat liver. 
A substantial improvement in hepatic function. 
compared with livers stored in conventional EC 
solution. was demonstrated in U\\'-stored organs 
after 90 min of perfusion. as manifested by increased 
bile production. decreased transaminase release. and 
decreased glucose release into the perfusate. A sig-
nificant difference in perfusate LDH levels between 
EC- and UW-stored livers only became evident after 
24 h of preservation. 
Tamaki et al. (22) observed that livers that gained 
the least weight during preservation resumed a nor-
mal color and consistency more rapidly. did not 
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become congested or bleed. and had the best his-
tologic appearance dftrr re\'uscularizatiun dJld trans-
plantation. In agreement with the experiments of 
Tamaki et al.. the LOW-stored livers gained less 
weight than the EC-stored livers and demonstrated 
the best function after preservation. 
Preliminary results [rom our laboratory. compar-
ing liver preservation in the standard EC solution 
with the new V\\' solution using orthotopic liver 
transplantation in the rat. demonstrate improved 
graft survival in those rats receiving livers preserved 
in UW solution after 9 and 24 h of preservation (Liu 
T. personal communication). These initial transplan-
tation findings confirm our observations of the im-
proved status of the isolated perfused rat livers that 
were stored in U\\' solution. 
Controls that did not undergo any period of pres-
ervation. but undE'r\\'ent the same method of fha-
tion. exhibited completely intact endothelium in 
both the sinusoids and larger vessels. indicating that 
the changes seen in the experimental groups were 
not artifactual. The endothelial disruption seen most 
dramaticall~D in the sinusoids of the livers stored for 
24 h in EC solution may be the result of (a) true 
endothelial denudation during the reperfusion pe-
riod or (b) a deterioration of the endothelium's 
ability to adhere due to ischemiaireperfusion injury. 
thus allowing its disruption during the process of 
fixation. The degree of endothelial injury observed 
in the preserved livers correlated well with the 
degree of hepatic dysfunction manifested by the 24·h 
EC-stored li\'ers :\ correlation between liver dys-
function and SHere endothelial disruption has been 
reported by \1cKt'own et al. (23). The importance of 
endothelial inlun' after ischemia reperfusion has 
also been reported in other organs (24.25). 
The livers preserved in EC solution for 24 h 
exhibited severe hepatocytic vacuolar degeneration. 
which is characteristic of hypoxic injury (26.27). The 
severe hepatocellular injury was evident only in the 
24-h EC-stored livers. whereas endothelial injury 
was present to some extent even after 12 h of EC 
preser\'Jtion. It appears that the injury to the sinu-
soidal endothelium is an early event in ischemia 
reperfusion injury and that the ensuing microcircu-
latory failure then results in parenchymal hypoxia 
and vacuolar degeneration. 
Attempts to prevent or diminish ischemic injury 
associated with organ procurement and preservation 
have invoh'ed the utilization of several pharmaco-
logic agents (28-31). The PAF antagonist SRJ 63-441 
has been shown to have a protective effect on post-
ischemic hepatic function after warm ischemic in-
jury (8). In addition to its effects on platelets. PAF 
induces neutrophil aggregation and activation and 
aEDc~mber 1988 
superoxide anion release. and acts directly on \·as· 
cular endothelium to increase permeability 132). Rat 
platelets are thought to be unresponsi\'e to PAF 
[33.341. therefore PAF·mediated ischemic li\'er in· 
jury may be neutrophil·dependent. 
The 24·h L1W·stored livers from animals pretreat· 
ed with 20 mg kg of SRJ 63·441 produced signifi· 
cantly more bile than livers similarly stored from 
untreated animals. This is a notable improvement in 
hepatic synthetic function. Although the other pa-
rameters of Ih'er function evaluated in this study did 
not reach statistical significance. a sustained general 
trend toward impro\'ement was e\'ident for all vari· 
abies. 
In summary. the results of this study provide 
objective data to further substantiate the superiority 
of UW solution over EC solution in Ii\'er preserva-
tion. Pretreatment of donors with SRI 63·H 1 is also 
beneficial in the further reduction of cold ischemic 
injury. resulting in improved postischemic hepatic 
function. The isolated perfused rat li\'er has proved 
to be an excellent model for the study of hepatic 
function after preservation. as it correlates well with 
the technically more difficult in \'ivo studies. 
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